AR031970A1 - Composicion farmaceutica solida termoformable para la liberacion controlada de ivabradina - Google Patents

Composicion farmaceutica solida termoformable para la liberacion controlada de ivabradina

Info

Publication number
AR031970A1
AR031970A1 ARP010106026A ARP010106026A AR031970A1 AR 031970 A1 AR031970 A1 AR 031970A1 AR P010106026 A ARP010106026 A AR P010106026A AR P010106026 A ARP010106026 A AR P010106026A AR 031970 A1 AR031970 A1 AR 031970A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
controlled release
solid pharmaceutical
ivabradina
thermoformable
Prior art date
Application number
ARP010106026A
Other languages
English (en)
Spanish (es)
Inventor
Patrick Wuthrich
Herve Rolland
Gilles Briault
Gerald Pichon
Francois Tharrault
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR031970A1 publication Critical patent/AR031970A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP010106026A 2000-12-26 2001-12-26 Composicion farmaceutica solida termoformable para la liberacion controlada de ivabradina AR031970A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0017014A FR2818549B1 (fr) 2000-12-26 2000-12-26 Composition pharmaceutique solide thermoformable pour la liberation controlee de trimetazidine

Publications (1)

Publication Number Publication Date
AR031970A1 true AR031970A1 (es) 2003-10-08

Family

ID=8858189

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010106029A AR032049A1 (es) 2000-12-26 2001-12-26 Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina
ARP010106026A AR031970A1 (es) 2000-12-26 2001-12-26 Composicion farmaceutica solida termoformable para la liberacion controlada de ivabradina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP010106029A AR032049A1 (es) 2000-12-26 2001-12-26 Una composicion farmaceutica solida termoformable para la liberacion controlada de trimetazidina

Country Status (3)

Country Link
AR (2) AR032049A1 (fr)
FR (1) FR2818549B1 (fr)
WO (1) WO2002051417A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885807B1 (fr) * 2005-05-18 2008-05-16 Mg Pharma Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation
WO2009066315A2 (fr) * 2007-08-08 2009-05-28 Usv Limited Compositions à libération prolongée de trimétazidine et procédé de préparation
WO2009034541A2 (fr) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Formes galéniques à libération contrôlée à base de trimétazidine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490963B1 (fr) * 1980-09-30 1986-04-18 Science Union & Cie Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine
JPH0625055B2 (ja) * 1985-03-18 1994-04-06 日本ケミフア株式会社 持続性錠剤
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
FR2717687B1 (fr) * 1994-03-24 1996-06-14 Adir Compositions pharmaceutiques permettant la libération prolongée de trimétazidine après administration par voie orale.
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates

Also Published As

Publication number Publication date
AR032049A1 (es) 2003-10-22
FR2818549A1 (fr) 2002-06-28
FR2818549B1 (fr) 2003-02-07
WO2002051417A1 (fr) 2002-07-04

Similar Documents

Publication Publication Date Title
AR022008A1 (es) Una composicion de liberacion controlada de galantamina, un proceso para la preparacion de la misma, y el uso de dicha composicion para la preparacion de un medicamento
CY1106390T1 (el) Στepεα θepμοδιαμορφωσιμη φαρμακευτικη συνθεση για την ελεγχομενη απελευθερωση της ιβαβραδινης
EA200000584A3 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
AR054114A1 (es) Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
ATE383165T1 (de) Pharmazeutische zusammensetzung mit verzögerter freisetzung, die wasserunlösliche komplexverbindungen enthalten
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
CY1108101T1 (el) Ενωσεις πυριμιδινης και η χρηση τους στην παρασκευη ενος τριαζολο-πυριμιδιν καρβα νουκλεοζιτη
GB2386361A (en) Packaging system
ATE252377T1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
AR026968A1 (es) Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral
CO5070569A1 (es) Compuesto de aminoazol o una sal farmaceuticamente aceptable del mismo y medicamento que los contienen
BR0212931A (pt) Composição farmacêutica de liberação prolongada contendo metformina
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR031970A1 (es) Composicion farmaceutica solida termoformable para la liberacion controlada de ivabradina
BR0314838A (pt) Sistema de liberação controlada, e, processo para preparar comprimidos de liberação controlada de temozolomida
AR031972A1 (es) Composicion farmaceutica solida termoformable para la liberacion controlada de perindopril
PT1190712E (pt) Composicao de esferas de tramadol para administracao oral uma vez por dia
GT199800008A (es) Procedimiento para la preparacion de un derivado de tetrahidropiridina.
UY26509A1 (es) Bases pirrolicas sustituidas de mannich, procedimiento para su preparación, medicamentos que contienen estos compuestos, y uso del compuesto para la preparación de medicamentos.
GT199800103A (es) Sales de sertralina y formas de dosificacion de liberacion sostenida de sertralina.
HN1999000145A (es) Uso de compuestos analogos a 1.3 oxatiolano-nucleosidos en la fabricacion de un medicamento para el tratamiento de la hepatitis b.
ECSP003358A (es) Composiciones de betahistina de liberacion controlada
HN2002000049A (es) Nuevos compuestos antiinflamatorios de triazolopiridinas
BR8001804Y1 (pt) embalagem para separação de produto.
ECSP003841A (es) Bases de mannich indólicas, procedimiento para su preparacion, medicamentos que contienen estos compuestos y su uso para la preparacion de medicamentos.

Legal Events

Date Code Title Description
FC Refusal